Table 5.
TNF-α | IL-6 | PAI-1 | TAFI-1 | hs-CRP | |
---|---|---|---|---|---|
Paraplegia SCI (n = 35) | |||||
SAT volume | 0.26 | 0.15 | 0.43* | −0.16 | 0.28 |
VAT volume | 0.25 | 0.03 | 0.40* | −0.12 | 0.16 |
VAT/SAT ratio | 0.07 | −0.07 | 0.19 | −0.13 | −0.09 |
Tetraplegia SCI (n = 12) | |||||
SAT volume | 0.50 | 0.00 | −0.35 | −0.12 | 0.35 |
VAT volume | 0.49 | 0.30 | −0.21 | 0.15 | 0.45 |
VAT/SAT ratio | 0.18 | 0.29 | 0.24 | 0.35 | 0.16 |
Note: hs-CRP, High-sensitivity c-reactive protein; IL-6, interleukin-6; PAI-1, plasminogen activatable inhibitor-1; SAT, subcutaneous adipose tissue; TAFI-1, thrombin activatable fibrinolysis inhibitor-1; TNF- α, tumor necrosis factor-α; VAT, visceral adipose tissue.
*p < 0.05.